<DOC>
	<DOCNO>NCT01517009</DOCNO>
	<brief_summary>The purpose study determine feasibility chemotherapy , consist docetaxel , cisplatin capecitabine give prior surgery stomach cancer . Furthermore , extend type removal lymph node implement .</brief_summary>
	<brief_title>A Multicenter Phase II Study Neoadjuvant Docetaxel , Cisplatin Capecitabine Protocolized Surgery Resectable Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>IbIVa histological proven resectable gastric adenocarcinoma , include gastrooesophageal junction/cardia carcinoma Siewert 2 3 ASA 2 less Age 18 year No prior radio chemotherapy conflict treatment gastric cancer Haematology/Renal function/Liver function within designated range Patient 's consent form obtain , sign date begin specific protocol procedure absence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule ; condition discuss patient registration trial patient registration/randomization , write informed consent must give accord GCP , WMO local regulation . Previous current malignancy , exception adequately treat situ carcinoma cervix uteri nonmelanoma skin cancer Other current serious illness medical condition Severe cardiac illness ( NYHA class IIIIV ) Significant neurologic psychiatric disorder Uncontrolled infection Active DIC Other serious underlie medical condition could impair ability patient participate study Known hypersensitivity docetaxel ( drug formulate Polysorbate80 ) , cisplatin capecitabine 5FU Definite contraindication use corticosteroid Use immunosuppressive antiviral drug Any experimental drug within 4week period prior start neoadjuvant chemotherapy throughout study period Pregnant lactate woman Patients reproductive potential implementing adequate contraceptive measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Neo-adjuvant chemotherapy</keyword>
	<keyword>D1extra-resection</keyword>
</DOC>